Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data

BACKGROUND: Several randomized controlled trials have shown that adjuvant immunotherapy with autologous cytokine-induced killer (CIK) cells prolongs recurrence-free survival (RFS) after curative treatment for hepatocellular carcinoma (HCC). We investigated the efficacy of adjuvant immunotherapy with...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Jun Sik, Song, Byeong Geun, Lee, Jeong-Hoon, Lee, Hyo Young, Kim, Sun Woong, Chang, Young, Lee, Yun Bin, Cho, Eun Ju, Yu, Su Jong, Sinn, Dong Hyun, Kim, Yoon Jun, Lee, Joon Hyeok, Yoon, Jung-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543598/
https://www.ncbi.nlm.nih.gov/pubmed/31151419
http://dx.doi.org/10.1186/s12885-019-5740-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543598/
https://www.ncbi.nlm.nih.gov/pubmed/31151419
http://dx.doi.org/10.1186/s12885-019-5740-z

Ejemplares similares